Atlas Trials

Single-arm, Prospective Study of the Efficacy and Safety of Paiteling®Antibacterial Liquid in the Treatment of Persistent Cervical HR-HPV Infection

Clinical trial NCT07493824 · RECRUITING

Trial details

NCT number
NCT07493824
Sponsor
The First Hospital of Jilin University
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Persistent HR-HPV Infection of the Cervix
Start date
2025-07-24
Primary completion
2028-05-31
Enrollment
115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.